BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6282413)

  • 1. Calcitonin effects on isolated bone cells.
    Shlossman M; Brown M; Shapiro E; Dziak R
    Calcif Tissue Int; 1982 Mar; 34(2):190-6. PubMed ID: 6282413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of the 3',5'-cyclic adenosine monophosphate and protein kinase C pathways on the response of isolated rat osteoclasts to calcitonin.
    Su Y; Chakraborty M; Nathanson MH; Baron R
    Endocrinology; 1992 Sep; 131(3):1497-502. PubMed ID: 1324163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,25-dihydroxycholecalciferol and parathormone: effects on isolated osteoclast-like and osteoblast-like cells.
    Wong GL; Luben RA; Cohn DV
    Science; 1977 Aug; 197(4304):663-5. PubMed ID: 195343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of synthetic muramyl dipeptide on bone metabolism in the fetal rat.
    Dziak R; Rowe DJ; Brown MJ; Hausmann E
    Arch Oral Biol; 1982; 27(10):787-91. PubMed ID: 6297436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of calcitonin, parathyroid hormone and prostaglandin E2 on cyclic AMP levels of isolated osteoclasts.
    Ito MB; Schraer H; Gay CV
    Comp Biochem Physiol A Comp Physiol; 1985; 81(3):653-7. PubMed ID: 2863055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone resorption by isolated chick osteoclasts in culture is stimulated by murine spleen cell supernatant fluids (osteoclast-activating factor) and inhibited by calcitonin and prostaglandin E2.
    de Vernejoul MC; Horowitz M; Demignon J; Neff L; Baron R
    J Bone Miner Res; 1988 Feb; 3(1):69-80. PubMed ID: 3264994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of peptides from the calcitonin genes on bone and bone cells.
    Zaidi M; Chambers TJ; Bevis PJ; Beacham JL; Gaines Das RE; MacIntyre I
    Q J Exp Physiol; 1988 Jul; 73(4):471-85. PubMed ID: 2845462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amylin inhibits bone resorption by a direct effect on the motility of rat osteoclasts.
    Alam AS; Moonga BS; Bevis PJ; Huang CL; Zaidi M
    Exp Physiol; 1993 Mar; 78(2):183-96. PubMed ID: 8385961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New model for bone resorption study in vitro: human osteoclast-like cells from giant cell tumors of bone.
    Grano M; Colucci S; De Bellis M; Zigrino P; Argentino L; Zambonin G; Serra M; Scotlandi K; Teti A; Zambonin Zallone A
    J Bone Miner Res; 1994 Jul; 9(7):1013-20. PubMed ID: 7942147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term culture of disaggregated rat osteoclasts: inhibition of bone resorption and reduction of osteoclast-like cell number by calcitonin and PTHrP[107-139].
    Fenton AJ; Martin TJ; Nicholson GC
    J Cell Physiol; 1993 Apr; 155(1):1-7. PubMed ID: 8468357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcitonin effects on osteoclastic resorption: the 'escape phenomenon' revisited.
    Heersche JN
    Bone Miner; 1992 Mar; 16(3):174-7. PubMed ID: 1314121
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison between the effects of forskolin and calcitonin on bone resorption and osteoclast morphology in vitro.
    Lerner UH; Ransjö M; Klaushofer K; Hörandner H; Hoffmann O; Czerwenka E; Koller K; Peterlik M
    Bone; 1989; 10(5):377-87. PubMed ID: 2605053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoblast adherence and resorption activity of isolated osteoclasts on calcium sulphate hemihydrate.
    Sidqui M; Collin P; Vitte C; Forest N
    Biomaterials; 1995 Nov; 16(17):1327-32. PubMed ID: 8573671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP.
    MacIntyre I; Zaidi M; Alam AS; Datta HK; Moonga BS; Lidbury PS; Hecker M; Vane JR
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2936-40. PubMed ID: 1849281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that the action of calcitonin on rat osteoclasts is mediated by two G proteins acting via separate post-receptor pathways.
    Zaidi M; Datta HK; Moonga BS; MacIntyre I
    J Endocrinol; 1990 Sep; 126(3):473-81. PubMed ID: 2170558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the role of cyclic AMP as a mediator of bone resorption: gamma-interferon completely inhibits cholera toxin- and forskolin-induced but only partially inhibits parathyroid hormone-stimulated 45Ca release from mouse calvarial bones.
    Lerner UH; Ransjö M; Ljunggren O; Klaushofer K; Hoffmann O; Peterlik M
    J Bone Miner Res; 1991 Jun; 6(6):551-60. PubMed ID: 1653515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-bone-resorptive agent calcitonin also acts in vitro to directly increase bone formation and bone cell proliferation.
    Farley JR; Tarbaux NM; Hall SL; Linkhart TA; Baylink DJ
    Endocrinology; 1988 Jul; 123(1):159-67. PubMed ID: 3383771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical characterization with parathormone and calcitonin of isolated bone cells: provisional identification of osteoclasts and osteoblasts.
    Luben RA; Wong GL; Cohn DV
    Endocrinology; 1976 Aug; 99(2):526-34. PubMed ID: 182458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of continuous calcitonin treatment on osteoclast-like cell development and calcitonin receptor expression in mouse bone marrow cultures.
    Ikegame M; Rakopoulos M; Martin TJ; Moseley JM; Findlay DM
    J Bone Miner Res; 1996 Apr; 11(4):456-65. PubMed ID: 8992876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of amylin in bone.
    Tamura T; Miyaura C; Owan I; Suda T
    J Cell Physiol; 1992 Oct; 153(1):6-14. PubMed ID: 1325980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.